Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistCosmetic Specialty Labs, Inc. was cited for significant Current Good Manufacturing Practice (CGMP) violations in the manufacturing of over-the-counter drug products including pain relievers, hand sanitizers, and sunscreens. The company's quality control unit failed to establish adequate oversight and ensure drug products met established specifications for identity, strength, quality, and purity, rendering the products adulterated. Additionally, at least one drug product was not properly listed with the FDA as required by law, making it misbranded and prohibited from interstate commerce. The violations were identified during an FDA inspection conducted in September 2023 at the facility in Lawton, Oklahoma.